B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Altimmune (ALT – Research Report) yesterday and set a price target of ...

In a report released yesterday, Mayank Mamtani from B.Riley Financial maintained a Buy rating on Viking Therapeutics (VKTX – Research Report), ...

Learn about the latest financial trends and strategies in our comprehensive article written by a financial expert.

I have covered B. Riley Financial, Inc. or "B. Riley" (NASDAQ:RILY, NASDAQ:RILYL, NASDAQ:RILYP, NASDAQ:RILYM, NASDAQ:RILYK, NASDAQ:RILYN, NASDAQ:RILYG, NASDAQ:RILYT ...

Frederick J. Lawrence, the ex-Independent Petroleum Association of America (IPAA) Chief Economist, told Rigzone in a separate ...

As of the latest trading close, RC, a Real Estate sector stock, is trading -30.72% below its 52-week high but remains 7.03% above its 52-week low. The Average True Range (ATR) (14 days) of 0.2 ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 30.90% ...

Alcoa Co. (NYSE:AA – Free Report) – Stock analysts at B. Riley boosted their FY2024 EPS estimates for shares of Alcoa in a research report issued on Tuesday, January 21st. B. Riley analyst L.

Research analysts at B. Riley boosted their FY2024 earnings per share (EPS) estimates for Gentex in a report issued on Tuesday, January 21st. B. Riley analyst J. Nichols now anticipates that the auto ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

President Donald Trump is poised to sign the first bill of his new administration. It's named after a slain Georgia nursing ...